Kidney insufficiency and cardiovascular disease;Niereninsuffizienz und kardiovaskuläre erkrankungen

Internist

Volumn 48, Issue 8, 2007, Pages 770-778

  Weidtmann, B ^a   Schunkert, H ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cardiovascular disease; Chronic renal disease; Haemodialysis; Left ventricular hypertrophy; Mortality

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; METOPROLOL;

ACUTE CORONARY SYNDROME; ARTERIOSCLEROSIS; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIALYSIS; DISEASE COURSE; ENDOCRINE DISEASE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FAILURE; METABOLIC DISORDER; MORBIDITY; MORTALITY; POPULATION; RISK FACTOR; UREMIA;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ENDOMYOCARDIAL FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 34548533607     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1901-2     Document Type: Article

References (33)

1. Amann K, Ritz E (2000) Microvascular disease-the cinderella of uremic heart disease. Nephrol Dial Transplant 15: 1493-1503
2. Amann K, Törnig J, Flechtenmacher C et al. (1995) Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive role of PTH. Nephrol Dial Transplant 10: 2043-2048
3. Breithardt G für die AdHoc-Arbeitsgruppe (2006) Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz. Teil I und II. Clin Res Cardiol Suppl 1: 8-30; 103-117
4. Clyne N, Lins LE, Pehrsson SK (1986) Occurrence and significance of heart disease in uraemia. Scand J Urol Nephrol 20: 307-311
5. Collins AJ, Li S, Ma JZ, Herzog C (2001) Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis (Suppl 1) 38: S26-S29
6. Foley RN, Parfrey PS, Harnett JD et al. (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192
7. Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9: S16-S23
8. Goodman WG, Goldin J, Kuizon BD et al. (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483
9. Guérin AP, London GM, Marchais SJ, Métivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15: 1014-1021
10. Herzog CA, Ma JZ, Collins AJ (1998) Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339: 799-805
11. Holdaas H, Fellstrom B, Jardine AG et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361: 2024-2031
12. Hüting J, Kramer W, Schütterle G, Wizemann V (1988) Analysis of left ventricular changes associated with chronic hemodialysis. Nephron 49:284-290
13. K/DOQI NKF (2005) Clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45: S1-S153
14. Levin A (2002) Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 80: 35-38
15. Lieb W, Mayer B, Stritzke J et al. (2006) Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echokardiographic Substudy. Nephrol Dial Transplant 21: 2780-2787
16. Lindner A, Charra B, Sherrad DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701
17. London GM (2001) Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant (Suppl 2) 16: S3-S6
18. Mall G, Rambausek M, Neumeister A et al. (1988) Myocardial interstitial fibrosis in experimental uremia. Implications for cardiac compliance. Kidney Int 33: 804-811
19. Meier-Kriesche HU, Schold JD, Srinivas TR et al. (2004) Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Tranplant 4: 1662-1668
20. Parfrey PS, Foley RN, Harnett JD et al. (1996) Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 49: 1428-1434
21. Rambausek M, Ritz E, Mall G et al. (1985) Myocardial hypertrophy in rats with renal insufficiency. Kindey Int 28:775-787
22. Rigatto C, Foley R, Kent G et al. (2000) Long term changes in left ventricular hypertrophy following renal transplantation. Transplantation 70: 570-575
23. Rinehart AL, Herzog CA, Collins AJ et al. (1995) A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 25: 281-290
24. Ritz E, Amann K, Törnig J et al. (1998) Some cardiac abnormalities in renal failure. In: Grünfeld JP, Bach JF, Kreis H et al. (eds) Advances in nephrology. Vol. 27. Mosby, St. Louis, USA, pp 85-103
25. Rostand SG, Kirk KA, Rutsky EA (1984) Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kindey Int 25:653-659
26. Rubenstein MH, Harrell LC, Sheynberg BV et al. (2000) Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 102: 2966-2977
27. Silberberg J, Racine N, Barre P, Sniderman AD (1990) Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6: 1-4
28. Shlipak MG, Heidenreich PA, Noguchi H et al. (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137: 555-562
29. Stritzke J, Mayer B, Lieb W et al. (in press) Haematocrit levels and left ventricular geometry: results of the MONICA Augsburg Echocardiographic Substudy. J Hypertension
30. U.S. Renal Data Systems (2002) USRDS 2002 Annual Data Report. In: Bethesda MD (ed) The National Institutes of Health, National Institute of Diabetes and Digestive Diseases
31. Wanner C, Krane V, Marz W et al. (2004) Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study). Kidney Blood Press Res 27: 259-266
32. Wolfe RA, Ashby VB, Milford EL et al. (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730
33. Zocalli C, Benedetto FA, Mallamaci F et al. (2001) Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 12: 2768-2774